Neurodevelopmental disorders are a huge unmet medical need with a high burden for patients and society. Neurolentech´s vision is to become the world-leading company for patient-specific, molecularly defined cellular models in preclinical drug development for autism, epilepsy, and intellectual disability.
Company Details
- Employees
- 11
- Founded
- 2021
- Address
- Ploecking 1, Klosterneuburg,niederösterreich 3400,austria
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://neurolentech.com
- Keywords
- cell models, neurodevelopmental disorders, autism, epilepsy, intellectual disability, stem cells.
- HQ
- Klosterneuburg, Niederösterreich
Neurolentech Gmbh Questions
Neurolentech Gmbh's website is https://neurolentech.com
Neurolentech Gmbh's LinkedIn profile is https://at.linkedin.com/company/neurolentech-gmbh
Neurolentech Gmbh has
11 employees.
View email and phone details for 11
employees at Neurolentech Gmbh.
Neurolentech Gmbh's industry is
Biotechnology Research
Neurolentech Gmbh's top competitors are
Healiva®,
A:head Bio Ag,
Valanx Biotech,
Ribbon Bio,
Syntropic,
Proxygen,
Myllia Biotechnology,
Solgate,
Acib Gmbh,
Kaerus Bioscience Ltd..
Neurolentech Gmbh's categories are Biotechnology Research
Neurolentech Gmbh's founding year is 2021
